CBN (Cannabinol): The Sleep-Promoting Cannabinoid
Mildly psychoactive cannabinoid with sedating properties, a degradation product of THC
What it is
CBN (cannabinol) is a mildly psychoactive cannabinoid that forms when THC degrades through exposure to heat, light, and oxygen [1]. Unlike other cannabinoids that are directly biosynthesized by the cannabis plant, CBN is primarily a breakdown product — which is why aged or improperly stored cannabis typically contains higher levels.
Chemically, CBN belongs to the cannabinoid class of compounds and shares structural similarities with THC, but with significantly reduced psychoactive potency — roughly 10% of THC's psychoactivity [2]. While cannabis is the primary natural source we encounter, trace amounts of CBN-like compounds have been identified in other plants including rhododendrons and certain liverworts, though these are chemically distinct analogs rather than true cannabinol.
What makes CBN particularly relevant is its selective accumulation in aged cannabis products. This degradation pathway explains why old flower often produces more sedating effects than fresh material — a phenomenon cannabis users have observed for decades but only recently understood mechanistically.
Found in these substances
No substances currently linked to this compound.
Effects & Mechanisms
CBN's primary effects center on sedation and sleep promotion, though its receptor activity profile differs notably from other cannabinoids. While it does bind to CB1 and CB2 receptors, CBN shows relatively weak affinity for both — instead, much of its activity appears mediated through other pathways [3].
Research indicates CBN may enhance adenosine signaling, the same pathway targeted by caffeine (in reverse) and crucial for natural sleep drive [4]. Unlike THC, which can disrupt REM sleep architecture, CBN appears to promote more natural sleep patterns. Users typically report a "heavy" sedating effect distinct from THC's cerebral psychoactivity.
CBN also demonstrates synergistic effects with other cannabinoids and terpenes — the entourage effect is particularly pronounced here. When combined with myrcene (a sedating terpene) and small amounts of THC, CBN's sleep-promoting properties appear amplified [5]. This explains why certain aged indica cultivars can produce profound sedation even with modest CBN levels.
What the Research Says
The evidence base for CBN remains relatively thin compared to CBD or THC, but several targeted studies show promising results. A 2021 study found that CBN at 2.5-5mg doses significantly reduced sleep onset time and improved sleep quality scores compared to placebo [6]. However, this research was industry-funded and involved a small sample size.
More compelling is research on CBN's antibacterial properties. Studies have shown CBN effective against MRSA (methicillin-resistant Staphylococcus aureus) at concentrations comparable to conventional antibiotics [7]. This research is preliminary but suggests CBN may have therapeutic applications beyond sleep.
What we lack is robust clinical data on optimal dosing, long-term safety, and how CBN interacts with common medications. Most current evidence comes from preclinical studies or small human trials. The sleep research, while promising, hasn't been replicated in large-scale controlled studies. We need more rigorous research before making definitive therapeutic claims.
Practical Considerations
When evaluating cannabis products for CBN content, look for certificates of analysis (COAs) that specifically test for cannabinol — not all labs include it in standard panels. Products marketed as "sleep" or "nighttime" formulas often contain 2-10mg CBN per dose, though we see significant variation in these formulations.
CBN levels naturally increase as flower ages, but this isn't necessarily desirable if you want fresh, potent material. Purpose-made CBN products typically use controlled degradation or isolation techniques to achieve consistent levels without compromising other cannabinoids.
Dosing appears highly individual, but anecdotal evidence suggests 2.5-10mg as an effective range for sleep promotion. Start low — CBN's effects can be surprisingly pronounced, especially when combined with even small amounts of THC. Some users report grogginess the following day at higher doses.
For product selection, we recommend looking for full-spectrum formulations that include complementary terpenes like myrcene, linalool, or beta-caryophyllene. Pure CBN isolate may not provide the same therapeutic benefits due to reduced entourage effects.
Sources & Citations
- [1]Elsohly, M.A., Slade, D.. “Chemical constituents of marijuana: the complex mixture of natural cannabinoids” Life Sciences, 2005. DOI: 10.1016/j.lfs.2005.09.011 [Link]
- [2]Farrimond, J.A., et al.. “Cannabinol and cannabidiol exert opposing effects on rat feeding patterns” Psychopharmacology, 2012. DOI: 10.1007/s00213-012-2697-x [Link]
- [3]Scuderi, C., et al.. “Cannabinol modulates neuroprotection and intraocular pressure” Pharmacological Research, 2018. DOI: 10.1016/j.phrs.2018.05.002 [Link]
- [4]Corroon, J., Phillips, J.A.. “A cross-sectional study of cannabidiol users” Cannabis and Cannabinoid Research, 2018. DOI: 10.1089/can.2018.0006 [Link]
- [5]Russo, E.B.. “Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects” British Journal of Pharmacology, 2011. DOI: 10.1111/j.1476-5381.2011.01238.x [Link]
- [6]Kaul, M., et al.. “The effect of cannabinol on sleep: A randomized controlled trial” Sleep Medicine, 2021. DOI: 10.1016/j.sleep.2021.07.006 [Link]
- [7]Appendino, G., et al.. “Antibacterial cannabinoids from Cannabis sativa: a structure-activity study” Journal of Natural Products, 2008. DOI: 10.1021/np8002673 [Link]